Pediatric Hepatobiliary Diseases and Treatments
Moving in Gastroenterology, Journal of hepatology, bioRxiv, medRxiv and Virulence.
- Moved, week to 6 Oct 2026
- 0
- Papers in 60 days
- 13
Add Pediatric Hepatobiliary Diseases and Treatments as an interest in JClubFree on the App Store · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Pediatric Hepatobiliary Diseases and Treatments
Newest first · last 60 days
The LiaFSR-SpxA2 regulatory axis is essential for bile salt resistance and virulence in Group B Streptococcus, with spxA2 deletion impairing membrane stability and pathogenicity.
- Open access
Browse JClub
Journals this month
- bioRxiv5920
- medRxiv1791
- PNAS493
- Environ Res491
- Sci Adv353
- JAMA259
- Cell Rep212
- BMJ209
- Nat Commun178
- Environ Pollution170
- Science139
- Curr Biol134
- Lancet130
- NEJM124
- Applied & Environ Microbio119
- mBio117
- Plant Cell Environ116
- J Exp Bot112
Topics moving, week to 6 Oct 2026
- Artificial Intelligence in Healthcare and Education7
- CAR-T cell therapy research7
- Single-cell and spatial transcriptomics6
- Lung Cancer Treatments and Mutations5
- Gut microbiota and health5
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Neuroinflammation and Neurodegeneration Mechanisms5
- Diabetes Treatment and Management4
- SARS-CoV-2 and COVID-19 Research3